VACCINE COMPOSITION FOR PROTECTION AGAINST TEGUMENTARY LEISHMANIASIS

摘要

The present technology relates to vaccine compositions comprising at least one of the nine peptides defined by SEQ ID NO 1-9, capable of stimulating the development of a T helper 1 (Th1)-type cell immune response with high production of interferon-gamma (IFN- ) and low levels of interleukin-4 (IL-4) for preventing tegumentary leishmaniasis in mammals.